What they were paid
Repare Therapeutics Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2024 | $75,771 | $0 | $72,352 | $1,078 | $149,201 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: Repare Therapeutics Inc. DEF 14A filed April 29, 2025, accession 0001193125-25-103764, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2024Repare Therapeutics pays directors a $40,000 cash retainer.
Committees
FY2024 · as the proxy prints themAudit · Nominating/Governance
The rest of the Repare Therapeutics board
FY2024 · as the company reported each| Director | Role | FY2024 total |
|---|---|---|
| Ann D. Rhoads | Independent Director | $130,138 |
| Carol A. Schafer | Independent Director | $128,806 |
| David Bonita, M.D | Independent Director | $119,060 |
| Samarth Kulkarni, Ph.D | Independent Director | $118,430 |
| Steve Forte | Director | $0 |
| Steven Stein, M.D | Independent Director | $172,311 |
| Susan M. Molineaux, Ph.D | Independent Director | $122,847 |
The full Repare Therapeutics compensation record
free company briefThis page is one director within Repare Therapeutics's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat